TG Therapeutics, Inc.
US ˙ NasdaqCM ˙ US88322Q1085

SecurityTGTX / TG Therapeutics, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Caption Management, LLC ownership in TGTX / TG Therapeutics, Inc.

On February 17, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 0 shares of TG Therapeutics, Inc. (US:TGTX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 50,276 shares of TG Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (TGTX) in the form of stock options. The firm currently holds call options representing 50,000 of underlying shares valued at $1,661,000 USD and put options representing 30,000 of underlying shares valued at $996,600 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -50,276 -100.00 0 -100.00
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 50,276 50,276 1,816 0.0142
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -33,300 -100.00 0 -100.00
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 33,300 33,300 278 0.0043
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -34,629 -100.00 0 -100.00
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 34,629 34,629 521 0.0101
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -425,000 -100.00 0 -100.00
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 425,000 355,000 507.14 2,516 744.30 0.0347
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 70,000 70,000 298 0.0041
2022-05-13 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -639,900 -100.00 0 -100.00
2022-02-11 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 639,900 594,900 1,322.00 12,159 711.68 0.1363
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 45,000 39,750 757.14 1,498 634.31 0.0171
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 5,250 5,250 204 0.0027
2020-11-16 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -8,800 -100.00 0 -100.00
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 8,800 -36,200 -80.44 172 -61.17 0.0057
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 45,000 45,000 411.36 443 157.56 0.0251
2019-01-30 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 0 -20,900 -100.00 0 -100.00
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 20,900 20,900 117 0.0065
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM Call 50,000 -16.67 1,661 -7.10 n/a n/a n/a
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM Call 60,000 -22.18 1,789 -35.80 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Call 77,100 144.76 2,785 145.81 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Call 31,500 194.39 1,134 169.12 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Call 10,700 -91.31 422 -88.65 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Call 123,200 310.67 3,708 428.96 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Call 30,000 702 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Call 23,200 -91.91 353 -92.81 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Call 286,800 62.03 4,899 231.17 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Call 177,000 -63.12 1,480 -87.59 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Call 479,900 132.85 11,921 284.64 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Call 206,100 -84.80 3,100 -80.68 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Call 1,356,000 856.95 16,041 1,814.20 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Call 141,700 -76.64 838 -67.49 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Call 606,700 234.09 2,578 49.10 n/a n/a n/a
2022-05-13 2022-03-31 13F TG THERAPEUTICS COM Call 181,600 1,729 n/a n/a n/a
2022-02-11 2021-12-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM Call 45,000 -55.00 1,498 -61.37 n/a n/a n/a
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM Call 100,000 3,878 n/a n/a n/a
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM Call 370,900 22.94 3,649 8.93 n/a n/a n/a
2020-02-13 2019-12-31 13F TG THERAPEUTICS COM Call 301,700 -18.66 3,350 -8.19 n/a n/a n/a
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F TG THERAPEUTICS COM Call 149,000 1,289 n/a n/a n/a
2019-01-30 2018-12-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM Call 174,900 979 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM Put 30,000 -81.21 997 -79.08 n/a n/a n/a
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM Put 159,700 0.69 4,761 -16.91 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Put 158,600 5,729 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Put 90,700 -41.75 3,576 -23.69 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Put 155,700 419.00 4,687 568.47 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Put 30,000 702 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Put 15,000 -78.57 228 -80.92 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Put 70,000 -44.88 1,196 12.63 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Put 127,000 78.37 1,062 -39.99 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Put 71,200 374.67 1,769 685.78 n/a n/a n/a
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM Put 15,000 -62.50 226 -52.43 n/a n/a n/a
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM Put 40,000 -53.38 473 -6.71 n/a n/a n/a
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM Put 85,800 87.34 507 160.00 n/a n/a n/a
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM Put 45,800 5,625.00 195 2,337.50 n/a n/a n/a
2022-05-13 2022-03-31 13F TG THERAPEUTICS COM Put 800 -99.87 8 -99.93 n/a n/a n/a
2022-02-11 2021-12-31 13F TG THERAPEUTICS COM Put 639,900 1,012.87 12,158 535.21 n/a n/a n/a
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM Put 57,500 130.00 1,914 97.52 n/a n/a n/a
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM Put 25,000 969 n/a n/a n/a
2019-01-30 2018-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM Put 193,300 1,083 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.